Changing patterns of Kaposi's sarcoma in N.E. Zaire
- PMID: 3603645
- DOI: 10.1016/0035-9203(86)90274-9
Changing patterns of Kaposi's sarcoma in N.E. Zaire
Abstract
A minor change in the pattern of Kaposi's sarcoma has been noticed in north-east Zaire. This is characterized by a small increase of the number of confirmed diagnoses, together with the appearance of the disease amongst women, who tend to be of a younger age group. These data suggests the appearance of a new aetiological factor in the area. From recent reports from other parts of Africa we speculate that this might be the appearance of HTLV-III virus.
PIP: Kaposi's sarcoma has been a familiar phenomenon to physicians in Central Africa for many years. In its classic presentation, Kaposi's sarcoma is a very slowly progressive disease of the extremities characterized by purple or hyperpigmented nodules, local chronic edema, and a typical histologic picture. There appears to be no connection between this endemic form of the disease and acquired immunodeficiency syndrome (AIDS). However, workers in the northeastern corner of Zaire are now encountering cases of atypical Kaposi, especially among females, that may be associated with seropositivity to the AIDS virus. In this area, the number of cases of Kaposi's sarcoma has increased from an average of 7/year before 1983 to 14 cases/year in 1983-85. From 1971-80, only 1 woman was diagnosed with Kaposi's sarcoma; however, 13 cases were confirmed among women in 1981-85 (5 in 1985 alone). The 10 women diagnosed in 1983-85 averaged 32 years of age and the 34 men diagnosed in this period averaged 40 years of age, indicating a trend toward younger age at onset of disease. The recent Kaposi's sarcoma cases have been of the nodular variety, with occasional visceral involvement. The changes in the pattern of Kaposi in northeast Zaire suggest the appearance of a new etiological factor in the area, quite possibly human immunodeficiency virus imported from other parts of Africa.
Similar articles
-
Lympho-cutaneous Kaposi's sarcoma in an African pediatric AIDS case.Am J Trop Med Hyg. 1989 Mar;40(3):323-5. doi: 10.4269/ajtmh.1989.40.323. Am J Trop Med Hyg. 1989. PMID: 2929857
-
The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma.Epidemiol Rev. 1991;13:178-99. doi: 10.1093/oxfordjournals.epirev.a036068. Epidemiol Rev. 1991. PMID: 1765111 Review.
-
Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.AIDS. 1997 Nov;11(13):1619-26. doi: 10.1097/00002030-199713000-00011. AIDS. 1997. PMID: 9365767
-
Antibody to the AIDS virus in Kaposi's sarcoma in Nigeria.J Surg Oncol. 1988 Mar;37(3):152-5. doi: 10.1002/jso.2930370303. J Surg Oncol. 1988. PMID: 3162540
-
Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma.J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1237-50. doi: 10.1016/0190-9622(90)70169-i. J Am Acad Dermatol. 1990. PMID: 2193952 Review.
Cited by
-
Construction of Immune Infiltration-Related LncRNA Signatures Based on Machine Learning for the Prognosis in Colon Cancer.Biochem Genet. 2024 Jun;62(3):1925-1952. doi: 10.1007/s10528-023-10516-4. Epub 2023 Oct 4. Biochem Genet. 2024. PMID: 37792224
MeSH terms
LinkOut - more resources
Full Text Sources
Medical